About
Rathna Mathiyalagan is an active researcher at the Faculty of Science and Engineering, focusing on pharmacy and health-related solutions. Their work primarily explores 3D printing technologies for veterinary pharmaceutical applications, including tailored drug delivery systems, chewable tablets, and enzyme delivery via nanomaterials. Key collaborations include researchers like X. Wang, N. Sandler, and J. Rosenholm.
Their research aligns with the UN Sustainable Development Goals, particularly in global health and advanced pharmaceutical solutions. Recent work involves semi-solid extrusion 3D printing for personalized veterinary dosage forms and mesoporous silica nanoparticles for enzyme delivery in hydrogels.
- 2025: Dual-release tablets for vomiting treatment
- 2025: Enzyme delivery in nanocomposite hydrogels
- 2023: Nanoformed piroxicam for veterinary use
- 2022: Chewable tablets via portable 3D printing
Rathna's publications highlight innovations in pharmaceutical technology and biomedical engineering, with applications in animal health and point-of-care manufacturing.
